Navigation Links
JCI table of contents: March 23, 2009
Date:3/23/2009

UTHOR CONTACT:
David M. Thomas
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Phone: 613-9656-1111; Fax: 613-9656-1411; E-mail: david.thomas@petermac.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=37175

ACCOMPANYING COMMENTARY
TITLE: Wnt therapy for bone loss: golden goose or Trojan horse?

AUTHOR CONTACT:
Greg H. Enders
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Phone: (215) 214-3956; Fax: (215) 728-4333; E-mail: Greg.Enders@fccc.edu.

View the PDF of this article at: https://www.the-jci.org/article.php?id=38973


GENE THERAPY: Making gene therapy safer using self-inactivating LTRs

Several patients in gene therapy clinical trials have developed leukemia as a result of their treatment. The underlying cause of leukemia is thought to be that the viral vectors used to carry the therapeutic gene into cells (gamma-RVs) integrate into the genome of the cells disrupting the natural control of cancer-associated genes (a process known as insertional mutagenesis). By analyzing specific elements of gamma-RVs and another type of viral vector, LVs, in a tumor-prone mouse model, a team of researchers, at San Raffaele-Telethon Institute for Gene Therapy, Italy, has now provided evidence that LVs are substantially less likely to cause insertional mutagenesis and tumors than gamma-RVs. Further, they found that modifying an element (known as the LTR) of both LVs and gamma-RVs such that it is self-inactivating (SIN) further improved safety. The authors therefore conclude that SIN viral vectors should be the preferred choice in future gene therapy trials.

In an accompanying commentary, Ute Modlich and Christo
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. JCI table of contents: Sept. 4, 2007
4. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
5. Actavis Launches Carvedilol Tablets in the U.S.
6. Mylan Announces Final FDA Approval for Carvedilol Tablets
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Actavis Launches Amlodipine Tablets in the U.S.
9. Implantable device designed to detect, stop seizures under study at MCG
10. Stevens Health, Technology and Society roundtable: Sept. 19
11. Fruity vegetables and fish reduce asthma and allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers ... to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its ... are committed to making sure patients have access to cannabis as a viable ...
(Date:7/7/2015)... , ... July 07, 2015 , ... At the end of June Pacific Prime Renewals ... ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not ... , On this initiative Cotton explained, “We send anything between 300 and 600 pieces ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune ... for its patient community using its IDF ePHR, an electronic personal health record ... diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, infusions ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Parents and guardians ... by A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse ... Drug Use and HIV Research has shown a significant increase in the “club drug” ...
(Date:7/7/2015)... ... 2015 , ... Georgia Partnership for TeleHealth (GPT), ... announces the launch of the first ambulance telemedicine program in the state, which ... new program will not only provide more immediate patient care, but will also ...
Breaking Medicine News(10 mins):Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... Association Urges Parents to Protect Their Preteens and Teens through ... as a pleasant day at the beach quickly turned into ... portions of his feet and suffering organ failure. Lynn Bozof,s ... a terrible headache, and within hours was admitted to the ...
... Color Touch Screen GPS Rangefinder IntroducedHOUSTON, Jan. 27 ... , its revolutionary new touch screen GPS rangefinder, ... OnPar is the first hand held color ... golfers the ultimate user experience. It,s like ...
... Product in New Bubble Gum Flavor for Ages Two ... McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today ... Syrup, a new sugar-free, dye-free bubble gum flavor product ... known as upper respiratory allergies, in children ages two ...
... Gupta,s Commitment to Enriching Quality of Life Through Exercise ... Council on Exercise (ACE), America,s leading authority on fitness ... training organizations in the world, today announced its support ... chief medical correspondent for the health and medical unit ...
... 27 HCA Healthcare announces the following Webcast:, What: ... @ 10:00 EST, Where: http://www.videonewswire.com/event.asp?id=55052 , ... the web at the, ... Healthcare, +1-615 ...
... Network Power, a business of Emerson and the global leader ... DA12-M series wall mount switching adapters, designed specifically for medical ... ... Carlsbad, CA (PRWEB) January 27, 2009 -- Emerson ...
Cached Medicine News:Health News:Video: Late Winter/Early Spring is Meningitis Peak Season: Is Your Preteen or Teen at Risk? 2Health News:OnPar(R) Redefines Golf Experience 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3Health News:American Council on Exercise (ACE) Endorses Appointment of Dr. Sanjay Gupta as Surgeon General of the United States 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 3
(Date:7/7/2015)...  Dedicated to promoting wellness and giving back to ... the purple pledge in support of Alzheimer,s & Brain-Awareness ... a time to shine a purple light for the ... people in our community who are affected by Alzheimer,s. ... and helps mobilize friends, family members, neighbors and coworkers ...
(Date:7/7/2015)... 7. Juli 2015 BioClinica®, Inc ... klinische Studien, gab heute bekannt, dass es mit ... bei Gewinnung und Erhalt von Patienten übernommen hat. ... MediciGlobal , Ltd. und Access to Patients, LLC. ... Dienst zum Auffinden von Patienten, die für die ...
(Date:7/7/2015)... California and BANGALORE , ... , a global technology provider of innovative clinical trial ... Reports, (Industry Standard Research Reports) recent publication named " ... Provider Performance (2015) ". ISR Reports is one of ... pharmaceutical industry, and this report evaluated 22 EDC and ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... , , PRINCETON, N.J., Jan. 8 Pharmasset, Inc. ... 28th Annual JPMorgan Healthcare Conference being held from January 11 to ... Schaefer Price, Pharmasset,s President and Chief Executive Officer, will provide an ... 2010 at 2:00 PM (PT). , To access a simultaneous webcast ...
... Mylan Inc. (Nasdaq: MYL ) today announced that, in ... term-loan borrowings that were due in 2011. As a result, ... , Mylan Chairman and CEO Robert J. Coury said: "The ... continued strong operating cash flows and our continuing effort to ...
Cached Medicine Technology:Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 3
... Re-insulation capabilities that extend the life of ... bring them back to life, expertise you ... trademark. Our maintenance capabilities always help you ... Economical and fast, not only do we ...
... know their instruments will consistently perform correctly. ... Instrument for instrument repair than any other ... carbide inserts and all repairs are micro-inspected ... enjoy 24-hour turnaround from our repair center ...
... fiber and video scopes including bronchoscopes, cystoscopes, ... OR and endoscopy. Quality is of utmost ... the standards of the OEM. We back ... defects in materials and workmanship. Quotes are ...
Inquire...
Medicine Products: